| Literature DB >> 22111707 |
C van den Dungen1, N Hoeymans, H C Boshuizen, M van den Akker, M C J Biermans, K van Boven, H J Brouwer, R A Verheij, M W M de Waal, F G Schellevis, G P Westert.
Abstract
BACKGROUND: General practice based registration networks (GPRNs) provide information on morbidity rates in the population. Morbidity rate estimates from different GPRNs, however, reveal considerable, unexplained differences. We studied the range and variation in morbidity estimates, as well as the extent to which the differences in morbidity rates between general practices and networks change if socio-demographic characteristics of the listed patient populations are taken into account.Entities:
Mesh:
Year: 2011 PMID: 22111707 PMCID: PMC3280203 DOI: 10.1186/1471-2458-11-887
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Socio-demographic characteristics of General Practice Registration Networks
| % male | Age distribution | SES distribution | Urbanization | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 < 20 | 20 < 65 | 65+ | Low | Medium | High | Very urban | Urban | Rural | 0 < 10 | 10 < 50 | 50 < 70 | ≥70 | ||||
| CMR-N | 10409 | 3 | 47.8 | 26.3 | 60.2 | 13.5 | 16.4 | 24.2 | 59.4 | 24.5 | 3.7 | 71.8 | 92.1 | 7.9 | 0.0 | 0.0 |
| HAG-net-AMC | 43930 | 7 | 47.4 | 24.7 | 63.9 | 11.4 | 79.7 | 13.0 | 7.3 | 86.0 | 0.4 | 13.5 | 13.7 | 9.8 | 60.3 | 16.3 |
| LINH | 327551 | 81 | 49.4 | 24.0 | 61.8 | 14.1 | 48.4 | 24.9 | 26.7 | 38.8 | 16.2 | 45.1 | 68.4 | 25.9 | 3.7 | 2.1 |
| RNUH-LEO | 34835 | 4 | 48.9 | 24.3 | 63.6 | 12.1 | 10.6 | 18.7 | 70.7 | 34.1 | 34.8 | 31.0 | 71.5 | 28.5 | 0.0 | 0.0 |
| Smile | 56799 | 9 | 48.5 | 22.9 | 59.6 | 17.5 | 70.1 | 7.4 | 22.5 | 66.7 | 22.0 | 11.4 | 17.0 | 83.0 | 0.0 | 0.0 |
| Trans | 13992 | 5 | 48.5 | 23.9 | 60.2 | 15.9 | 25.2 | 29.8 | 45.0 | 50.1 | 9.4 | 40.5 | 42.2 | 57.4 | 0.2 | 0.1 |
#NW immigrants = percentage of the population which live in neighbourhoods with almost no (0 < 10%), some (10 < 40%), many (40 < 70%) or most (≥70%) persons from non western origin
Variations in morbidity estimations of 13 diseases; incidence rates, prevalence rates and median odds ratios
| Diseases | ICPC1 Codes | Incidence | Prevalence | ||||
|---|---|---|---|---|---|---|---|
| Range of incidence (per 1000) | MOR (95%CI) | Range of prevalence (per 1000) | MOR (95%CI) | ||||
| Network | Practice | Network | Practice | ||||
| Gastrointestinal tract infection | D70, D73 | 10.4-28.2 | n/a | n/a | n/a | ||
| 1.22-2.75 | 1.40-1.68 | - | - | ||||
| Diabetes mellitus | T90 | 3.3-4.6 | 1.00 | 30.9-57.2 | |||
| 1.00-1.37 | 1.44-1.77 | 1.08-1.61 | 1.43-1.53 | ||||
| Depression | P03, P76 | 4.4-14.2 | 21.6-64.4 | ||||
| 1.14-3.04 | 1.29-1.52 | 1.27-3.05 | 1.61-1.79 | ||||
| Anxiety disorder | P01, P74 | 2.6-14.6 | 11.3-44.4 | ||||
| 1.22-4.26 | 1.39-1.67 | 1.29-3.32 | 1.65-1.82 | ||||
| Stroke | K89, K90 | 2.3-5.9 | 3.3-47.2 | ||||
| 1.10-2.49 | 1.33-1.65 | 1.42-4.28 | 1.74-1.88 | ||||
| CHD | K74, K75, | 2.8-5.4 | 1.00 | 9.7-47.2 | |||
| K76 | 1.00-1.86 | 1.51-1.95 | 1.35-4.57 | 1.75-1.97 | |||
| COPD | R91, R95 | 1.3-3.9 | 12.1-33.0 | ||||
| 1.09-2.87 | 1.39-1.73 | 1.14-2.14 | 1.57-1.73 | ||||
| Asthma | R96 | 2.9-6.2 | 29.2-60.0 | ||||
| 1.10-2.61 | 1.52-1.90 | 1.13-1.91 | 1.52-1.66 | ||||
| Urinary tract infection | U70, U71, | 29.4-46.1 | 1.19 | n/a | n/a | n/a | |
| U72 | 1.00-1.69 | 1.27-1.49 | - | - | |||
| Dermatitis | S88, S87 | 16.9-57.0 | 27.9-161.2 | ||||
| 1.05-1.70 | 1.21-1.38 | 1.39-3.72 | 1.50-1.62 | ||||
| Osteoarthritis | L89, L90, | 5.4-9.7 | 1.20 | 12.3-61.2 | |||
| L91 | 1.00-1.87 | 1.37-1.65 | 1.43-4.32 | 1.54-1.70 | |||
| Neck and back problems | L01, L02, | 42.3-78.9 | 29.8-302.5 | ||||
| L03, L83, | 1.13-1.94 | 1.19-1.33 | 1.63-6.44 | 1.35-1.43 | |||
| L84, L86 | |||||||
| Herpes zoster | S70 | 3.5-4.5 | 1.08 | n/a | n/a | n/a | |
| 1.00-1.34 | 1.11-1.36 | - | - | ||||
Bold variation among network versus practices is significant (p < 0.05).
Variation in Incidence data in MOR adjusted for population characteristics
| MOR (95%CI) | Model 0 | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| - | Age, gender | Age, gender, SES, ethnicity and urbanization level | ||||
| Network | Practice | Network | Practice | Network | Practice | |
| Gastrointestinal tract infection | ||||||
| 1.22-2.75 | 1.40-1.68 | 1.21-2.66 | 1.38-1.64 | 1.17-2.50 | 1.36-1.61 | |
| Diabetes mellitus | 1.00 | 1.00 | 1.00 | |||
| 1.00-1.37 | 1.44-1.77 | 1.00-1.42 | 1.46-1.81 | 1.00-1.49 | 1.48-1.87 | |
| Depression | ||||||
| 1.14-3.04 | 1.29-1.52 | 1.12-3.02 | 1.31-1.54 | 1.00-2.77 | 1.30-1.55 | |
| Anxiety disorder | ||||||
| 1.22-4.26 | 1.39-1.67 | 1.21-4.21 | 1.38-1.66 | 1.18-3.86 | 1.39-1.67 | |
| Stroke | 1.24 | |||||
| 1.10-2.49 | 1.33-1.65 | 1.03-2.08 | 1.30-1.56 | 1.00-2.02 | 1.29-1.40 | |
| CHD | 1.00 | 1.00 | -* | -* | ||
| 1.00-1.86 | 1.51-1.95 | 1.00-1.50 | 1.48-1.89 | |||
| COPD | ||||||
| 1.09-2.87 | 1.39-1.73 | 1.12-2.76 | 1.35-1.66 | 1.17-2.78 | 1.30-1.60 | |
| Asthma | ||||||
| 1.10-2.61 | 1.52-1.90 | 1.11-2.66 | 1.51-1.88 | 1.14-2.77 | 1.52-1.91 | |
| Urinary tract infection | 1.19 | |||||
| 1.00-1.69 | 1.27-1.49 | 1.00-1.70 | 1.27-1.44 | 1.00-1.68 | 1.25-1.42 | |
| Dermatitis | ||||||
| 1.05-1.70 | 1.21-1.38 | 1.04-1.68 | 1.21-1.38 | 1.00-1.67 | 1.20-1.36 | |
| Osteoarthritis | 1.20 | -* | -* | -* | -* | |
| 1.00-1.87 | 1.37-1.65 | |||||
| Neck and back problems | ||||||
| 1.13-1.94 | 1.19-1.33 | 1.13-1.94 | 1.19-1.35 | 1.07-1.74 | 1.17-1.31 | |
| Herpes zoster | 1.08 | 1.07 | 1.00 | |||
| 1.00-1.34 | 1.11-1.36 | 1.00-1.29 | 1.00-1.31 | 1.00-1.26 | 1.06-1.34 | |
Bold variation among network or variation among practices is significant (p < 0.05). *Analyses did not converge
Variation in prevalence data in MOR adjusted for population characteristics
| MOR (95%CI) | Model 0 | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| - | Age, gender | Age, gender, SES, ethnicity and urbanization level | ||||
| Network | Practice | Network | Practice | Network | Practice | |
| Diabetes mellitus | ||||||
| 1.08-1.61 | 1.43-1.53 | 1.07-1.58 | 1.43-1.53 | 1.04-1.39 | 1.35-1.44 | |
| Depression | ||||||
| 1.27-3.05 | 1.61-1.79 | 1.27-3.06 | 1.64-1.81 | 1.24-2.84 | 1.61-1.78 | |
| Anxiety disorder | ||||||
| 1.29-3.32 | 1.65-1.82 | 1.29-3.30 | 1.65-1.83 | 1.22-2.87 | 1.64-1.83 | |
| Stroke | ||||||
| 1.42-4.28 | 1.74-1.88 | 1.40-4.08 | 1.70-1.83 | 1.40-4.20 | 1.69-1.83 | |
| CHD | ||||||
| 1.35-4.57 | 1.75-1.97 | 1.33-4.20 | 1.82-1.96 | 1.27-3.55 | 1.82-1.96 | |
| COPD | ||||||
| 1.14-2.14 | 1.57-1.73 | 1.13-2.08 | 1.61-1.70 | 1.11-1.95 | 1.58-1.68 | |
| Asthma | ||||||
| 1.13-1.91 | 1.52-1.66 | 1.13-1.93 | 1.52-1.65 | 1.08-1.73 | 1.54-1.68 | |
| Dermatitis | ||||||
| 1.39-3.72 | 1.50-1.62 | 1.39-3.73 | 1.50-1.63 | 1.40-3.89 | 1.51-1.64 | |
| Osteoarthritis | ||||||
| 1.43-4.32 | 1.54-1.70 | 1.45-4.47 | 1.57-1.66 | 1.44-4.37 | 1.56-1.66 | |
| Neck and back problems | ||||||
| 1.63-6.44 | 1.35-1.43 | 1.66-6.94 | 1.38-1.47 | 1.68-7.32 | 1.37-1.45 | |
Bold variation among network or variation among practices is significant (p < 0.05)